A

Avalon Globocare Corp
NASDAQ:ALBT

Watchlist Manager
Avalon Globocare Corp
NASDAQ:ALBT
Watchlist
Price: 1.71 USD 23.91%
Market Cap: 7.3m USD

Avalon Globocare Corp
Other Long-Term Assets

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Avalon Globocare Corp
Other Long-Term Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Long-Term Assets CAGR 3Y CAGR 5Y CAGR 10Y
A
Avalon Globocare Corp
NASDAQ:ALBT
Other Long-Term Assets
$17.5k
CAGR 3-Years
-62%
CAGR 5-Years
-24%
CAGR 10-Years
N/A
Quest Diagnostics Inc
NYSE:DGX
Other Long-Term Assets
$296m
CAGR 3-Years
31%
CAGR 5-Years
13%
CAGR 10-Years
6%
CVS Health Corp
NYSE:CVS
Other Long-Term Assets
$7.1B
CAGR 3-Years
-5%
CAGR 5-Years
-5%
CAGR 10-Years
17%
Cigna Corp
NYSE:CI
Other Long-Term Assets
$15.2B
CAGR 3-Years
0%
CAGR 5-Years
9%
CAGR 10-Years
47%
Laboratory Corporation of America Holdings
NYSE:LH
Other Long-Term Assets
$648.1m
CAGR 3-Years
10%
CAGR 5-Years
8%
CAGR 10-Years
12%
Guardant Health Inc
NASDAQ:GH
Other Long-Term Assets
$151m
CAGR 3-Years
43%
CAGR 5-Years
94%
CAGR 10-Years
N/A
No Stocks Found

Avalon Globocare Corp
Glance View

Market Cap
7m USD
Industry
Health Care

Avalon GloboCare Corp. is a holding company, which engages in the development of biotechnology and the provision of healthcare services. The company is headquartered in Freehold, New Jersey and currently employs 5 full-time employees. The company went IPO on 2016-02-22. The firm is focused on the fields of cellular immunotherapy, including CAR-T/NK; exosome technology (ACTEX), and COVID-19-related vaccine and therapeutics through its subsidiaries. The company operates through two business segments: real property operating segment and medical related consulting services segment. The firm also provides strategic advisory and outsourcing services to facilitate and improve its clients’ growth and development, as well as competitiveness in healthcare and CellTech industry markets. Its downstream medical team and facility consists of affiliated hospital networks and experts specialized in hematology, oncology, cellular immunotherapy, hematopoietic stem/progenitor cell transplant, as well as regenerative therapeutics. Its clinical programs include AVA-001, ACTEX, FLASH-CAR, and AVA-Trap.

ALBT Intrinsic Value
HIDDEN
Show

See Also

What is Avalon Globocare Corp's Other Long-Term Assets?
Other Long-Term Assets
17.5k USD

Based on the financial report for Sep 30, 2025, Avalon Globocare Corp's Other Long-Term Assets amounts to 17.5k USD.

What is Avalon Globocare Corp's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 5Y
-24%

Over the last year, the Other Long-Term Assets growth was -92%. The average annual Other Long-Term Assets growth rates for Avalon Globocare Corp have been -62% over the past three years , -24% over the past five years .

Back to Top